Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 91: 2366-2373, 2001;
8750-7587/01 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lockshin, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lockshin, M. D.
Vol. 91, Issue 5, 2366-2373, November 2001

HIGHLIGHTED TOPICS
Genome and Hormones: Gender Differences in Physiology
Invited Review: Sex ratio and rheumatic disease*

Michael D. Lockshin

Barbara Volcker Center, Hospital for Special Surgery, Joan and Sanford I. Weill Medical College, Cornell University, New York, New York 10021

Human illnesses affect men and women differently. In some cases (diseases of sex organs, diseases resulting from X or Y chromosome mutations), reasons for sex discrepancy are obvious, but in other cases no reason is apparent. Explanations for sex discrepancy of illness occur at different biological levels: molecular (e.g., imprinting, X-inactivation), cellular (sex-specific receptor activity), organ (endocrine influences), whole organism (size, age), and environmental-behavioral, including intrauterine influences. Autoimmunity represents a prototypical class of illness that has high female-to-male (F/M) ratios. Although the F/M ratios in autoimmune diseases are usually attributed to the influence of estrogenic hormones, evidence demonstrates that the attributed ratios are imprecise and that definitions and classifications of autoimmune diseases vary, rendering at least part of the counting imprecise. In addition, many studies on sex discrepancy of human disease fail to distinguish between disease incidence and disease severity. In April 2001, the Institute of Medicine of the National Academy of Sciences published Exploring the Biological Contributions to Human Health: Does Sex Matter? (Wizemann T and Pardue M-L, editors). This minireview summarizes the section of that report that concerns autoimmune and infectious disease. Some thyroid, rheumatic, and hepatic autoimmune diseases have high F/M ratios, whereas others have low. Those that have high ratios occur primarily in young adulthood. Gonadal hormones, if they play a role, likely do so through a threshold or permissive mechanism. Examples of sex differences that could be caused by environmental exposure, X inactivation, imprinting, X or Y chromosome genetic modulators, and intrauterine influences are presented as alternate, theoretical, and largely unexplored explanations for sex differences of incidence. The epidemiology of autoimmune diseases (young, female) suggests that an explanation for sex discrepancy of these illnesses lies in differential exposure, vulnerable periods, or thresholds. Biologists have an opportunity to inform medical scientists about sex differences that explain different attack rates in specific diseases, and physicians offer biologists experiments of nature to test theories of sex.

autoimmunity; hormones; X chromosome; imprinting; environmental exposure


*  This paper derives largely from material published in the Institute of Medicine report Exploring the Biological Contributions to Human Health: Does Sex Matter? (copyright 2001 by the National Academy of Sciences). The full report can be viewed at http://www.nap.edu/catalog/10028.html.




This article has been cited by other articles:


Home page
Psychosom. Med.Home page
V. E. Burns, K. M. Edwards, C. Ring, M. Drayson, and D. Carroll
Complement Cascade Activation After an Acute Psychological Stress Task
Psychosom Med, May 1, 2008; 70(4): 387 - 396.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M M. Elloso, K. Phiel, R. A Henderson, H. A Harris, and S. J Adelman
Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands
J. Endocrinol., May 1, 2005; 185(2): 243 - 252.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Adamski and E. N. Benveniste
17{beta}-Estradiol Activation of the c-Jun N-Terminal Kinase Pathway Leads to Down-Regulation of Class II Major Histocompatibility Complex Expression
Mol. Endocrinol., January 1, 2005; 19(1): 113 - 124.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Adamski, Z. Ma, S. Nozell, and E. N. Benveniste
17{beta}-Estradiol Inhibits Class II Major Histocompatibility Complex (MHC) Expression: Influence on Histone Modifications and CBP Recruitment to the Class II MHC Promoter
Mol. Endocrinol., August 1, 2004; 18(8): 1963 - 1974.
[Abstract] [Full Text] [PDF]


Home page
J Intellect DisabilHome page
T. Thompson, M. Caruso, and K. Ellerbeck
Sex Matters in Autism and Other Developmental Disabilities
J Intellect Disabil., December 1, 2003; 7(4): 345 - 362.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online